Enzyme Immunoassay (EIA) Reagents and Kits Market Diagnosing the Future: The Rising Demand

Enzyme Immunoassay (EIA) Reagents And Kits Market worth $ XX Million by 2030 - Exclusive Report by InsightAce Analytic

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Enzyme Immunoassay (EIA) Reagents And Kits Market- by Product Type (Reagents and Kits), Technology (ELISA, Indirect ELISA, Sandwich ELISA, and Multiple/Portable ELISA), Application (Infectious Diseases,

Cardiology, Oncology, Bone and Mineral, Autoimmunity, Endocrinology, Toxicology, Neonatal Screening, Hematology, and Others), End-User (Hospital Laboratories, Clinical Laboratories, Pharmaceutical & Biotechnology Companies, Reference Laboratories, Academics and Others), Trends, Industry Competition Analysis, Revenue and Forecast To 2030."

Get a free sample copy of the report: https://www.insightaceanalytic.com/request-sample/1059

The global market for enzyme immunoassay (EIA) reagents and kits was valued at US$19.80 billion in 2021 [3]. According to a recent study by InsightAce Analytic, it is projected to grow at a compound annual growth rate (CAGR) of 5.5% between 2022 and 2030 [3].

Enzyme immunoassays (EIA) utilize reagents and equipment to detect and measure the presence or quantity of an antigen (a foreign substance that triggers an immune response) in a sample. These assays often employ various enzymes, including alkaline phosphatases and glucose oxidase. EIA tests have a wide range of applications across various medical fields such as cancer, toxicology, endocrinology, autoimmune diseases, hematology, and neonatal screening. The specific type of EIA technology used determines the test's capabilities.

The EIA reagents and equipment market is primarily driven by the growing global population and the rising prevalence of both infectious and chronic diseases. Chronic illnesses like diabetes, heart disease, and cancer are becoming increasingly common worldwide. Additionally, the prevalence of infectious diseases, including COVID-19, HIV, malaria, tuberculosis, dengue, hepatitis B and C, and others, is also a growing concern. Immunoassays, like EIA, have become a critical tool in diagnosing a vast array of diseases.

Furthermore, advancements in immunoassay technology are leading to faster results, improved efficacy, enhanced sensitivity, lower detection limits, and greater affordability. The increasing focus of pharmaceutical companies on R&D to develop novel drugs and healthcare solutions is also fueling the demand for EIA equipment and reagents. Finally, the expansion and growth of the biopharmaceutical industry further contribute to the continued expansion of the EIA reagents and equipment market.

North America is anticipated to be the major contributor to the Enzyme Immunoassay (EIA) Reagents And Kits market over the forecast years. This is due to the growing emphasis on creating new medications and biomarkers for various diseases.

In addition, encouraging government financing will help fuel the expansion of the reagents and equipment market for enzyme immunoassay (EIA) in this area. In addition, the Asia Pacific Enzyme Immunoassay (EIA) Reagents And Kits market is expected to grow significantly during the forecast period because more public and private money are being invested in equipment and reagents for enzyme immunoassay (EIA). Furthermore, chronic and infectious disease prevalence increases will further fuel market expansion.
Major market players operating in the Enzyme Immunoassay (EIA) Reagents And Kits market include

Affymetrix, Inc., American Laboratory Products Company, Thermo Fisher Scientific. Inc., BioMérieux SA, Beckman Coulter Inc., QIAGEN, Quidel, Ortho-Clinical Diagnostics, Inc., R&D Systems Inc., BD Biosciences, Life Technologies Corporation, ZEUS Scientific, Inc. and Other Prominent Players.

Recent collaborations and agreements in the market:
• In February 2021, Mesa Biotech, a private point-of-care molecular diagnostic company, was bought by Thermo Fisher Scientific Inc. Starting with COVID-19 testing, Mesa Biotech is a key component of the company's plan to increase the advantages of molecular diagnostics at the point of care.

• In January 2021, Abbott approved CE Mark for their Panbio COVID-19 Ag Rapid Test Device for asymptomatic SARS-CoV-2 viral diagnosis. It also has self-swabbing capabilities.

• In October 2020, for the detection of COVID-19 antibodies, Thermo Fisher Scientific introduced the EliA SARS-CoV-2-Sp1 IgG test and the OmniPATH COVID-19 Total Antibody ELISA test.

Curious about this latest version of the report? Obtain Report Details @ https://www.insightaceanalytic.com/enquiry-before-buying/1059

Market Segments
Global Enzyme Immunoassay (EIA) Reagents And Kits Market, by Technology, 2022-2030 (Value US$ Mn)
• Competitive ELISA
• Indirect ELISA
• Sandwich ELISA
• Multiple/portable ELISA

Global Enzyme Immunoassay (EIA) Reagents And Kits Market, by Product Type, 2022-2030 (Value US$ Mn)
• Reagents
• Kits

Global Enzyme Immunoassay (EIA) Reagents And Kits Market, by Application, 2022-2030 (Value US$ Mn)
• Infectious Diseases
• Cardiology
• Oncology
• Bone and Mineral
• Autoimmunity
• Endocrinology
• Toxicology
• Neonatal screening
• Hematology
• Others

Global Enzyme Immunoassay (EIA) Reagents And Kits Market, by End-Users, 2022-2030 (Value US$ Mn)
• Hospital Laboratories
• Clinical Laboratories
• Pharmaceutical & Biotechnology Companies
• Reference Laboratories
• Academics
• Others

Global Enzyme Immunoassay (EIA) Reagents And Kits Market, by Region, 2022-2030 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

North America Enzyme Immunoassay (EIA) Reagents And Kits Market, by Country, 2022-2030 (Value US$ Mn)
• U.S.
• Canada
Europe Enzyme Immunoassay (EIA) Reagents And Kits Market, by Country, 2022-2030 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe

Asia Pacific Enzyme Immunoassay (EIA) Reagents And Kits Market, by Country, 2022-2030 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand

Latin America Enzyme Immunoassay (EIA) Reagents And Kits Market, by Country, 2022-2030 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America

Middle East & Africa Enzyme Immunoassay (EIA) Reagents And Kits Market, by Country, 2022-2030 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa

Why should buy this report:
 To receive a comprehensive analysis of the prospects for the global Enzyme Immunoassay (EIA) Reagents And Kits market
 To receive an industry overview and future trends of the Enzyme Immunoassay (EIA) Reagents And Kits market
 To analyze the Enzyme Immunoassay (EIA) Reagents And Kits market drivers and challenges
 To get information on the Enzyme Immunoassay (EIA) Reagents And Kits market value (US$Mn) forecast to 2030
 Significant investments, mergers & acquisitions in the Enzyme Immunoassay (EIA) Reagents And Kits market industry

For More Customization @ https://www.insightaceanalytic.com/customisation/1059

Contact Us:
InsightAce Analytic Pvt. Ltd.
Tel.: +1 718 593 4405
Email: info@insightaceanalytic.com
Site Visit: www.insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions.
Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses.
We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products.
Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

This release was published on openPR.